Skip to main content

Table 1 Variables

From: The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

Treatment regimen

• NNRTI-based

• PI/r-based

• Other

Sociodemographic factors

Patient age (in years) at diagnosis

• < 50 years old

• 50 years or older

Education level

• With college degree

• Without college degree

Anamnestic factors

HIV stage according to CDC classification

• A (asymptomatic)

• B (symptomatic)

• C (AIDS-defining diseases)

More than three concomitant diseases

• No

• Yes